Back to search

Article

A Spatial Multi-Omic Framework Identifies Gliomas Permissive to TIL Expansion

2025-04-25

Abstract excerpt

<title>Abstract</title> <p>Tumor-infiltrating lymphocyte (TIL) therapy, recently approved by the FDA for melanoma, is an emerging modality for cell-based immunotherapy. However, its application in immunologically “cold” tumors such as glioblastoma remains limited due to sparse T cell infiltration, antigenic heterogeneity, and a suppressive tumor microenvironment. To identify genomic and spatial determinants of TI...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dd18d99c-badb-5f04-9564-9060347b1c4f
DOI
10.21203/rs.3.rs-6314842/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Spatial Multi-Omic Framework Identifies Gliomas Permissive to TIL ExpansionDOI 10.21203/rs.3.rs-6314842/v1
Select a neighboring publication to make it the new centre.